PROTAC RIPK degrader-2 is a non-peptide construct that utilizes von Hippel-Lindau ligands to selectively target and degrade the serine-threonine kinase RIPK2. Its structural design enhances cell death and activates ion channels in cancer cells while also disrupting protein interactions between receptors and ligands associated with various conditions, including cancer and diabetes.
Usually ships within 24 hours.